Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCGA8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,584
Award facts
- Contract value 100% obligated
- $31,584.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 21, 2026, for Xolair 150 mg/ml syringes with a ceiling value of $31,584.40 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. The underlying IDC, awarded to DMS Pharmaceutical on November 13, 2025, carries a $499.999 billion ceiling and runs through December 31, 2036, with a 30-month base period and three 30-month option periods.
DMS Pharmaceutical is a woman-owned small business headquartered in Park Ridge, Illinois. Place of performance for this delivery order is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of June 12, 2026.
This delivery order reflects routine pharmaceutical supply ordering under PPV-G GEN V; DMS Pharmaceutical operates as the sole regional prime vendor within the program's acquisition structure and issues delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables on a full-and-open basis.
Quick answers
Who was awarded contract SPE2DR26FCGA8?
SPE2DR26FCGA8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 21, 2026.
How much is contract SPE2DR26FCGA8 worth?
The government has obligated $31,584 on SPE2DR26FCGA8.
Is contract SPE2DR26FCGA8 an order under another contract?
Yes. SPE2DR26FCGA8 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCGA8 competed?
The extent of competition for SPE2DR26FCGA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award